The pharmacokinetic and pharmacodynamic properties of vancomycin
Top Cited Papers
Open Access
- 31 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (Supplement), S35-S39
- https://doi.org/10.1086/491712
Abstract
Vancomycin is one of only a few antibiotics available to treat patients infected with methicillin-resistant Staphylococcus aureus and methicillin-resistant, coagulase-negative Staphylococcus species. Therefore, understanding the clinical implications of the pharmacokinetic and pharmacodynamic properties of vancomycin is a necessity for clinicians. Vancomycin is a concentration-independent antibiotic ( also referred to as a "time-dependent" antibiotic), and there are factors that affect its clinical activity, including variable tissue distribution, inoculum size, and emerging resistance. This article reviews the pharmacokinetic and pharmacodynamic data related to vancomycin and discusses such clinical issues as toxicities and serum concentration monitoring.This publication has 40 references indexed in Scilit:
- Treatment Outcomes for Serious Infections Caused by Methicillin‐ResistantStaphylococcus aureuswith Reduced Vancomycin SusceptibilityClinical Infectious Diseases, 2004
- Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of EndocarditisAntimicrobial Agents and Chemotherapy, 2003
- Emergence of Methicillin-Resistant Staphylococcus aureus with Intermediate Glycopeptide ResistanceDrugs, 2001
- Vancomycin-Intermediate and -Resistant Staphylococcus aureus: What the Infectious Disease Specialist Needs to KnowClinical Infectious Diseases, 2001
- The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditionsJournal of Antimicrobial Chemotherapy, 1996
- Nephrotoxicity of vancomycin, alone and with an aminoglycosideJournal of Antimicrobial Chemotherapy, 1990
- The Influence of Serum Albumin and ??1-Acid Glycoprotein on Vancomycin Protein Binding in Patients with Burn InjuriesJournal of Burn Care & Rehabilitation, 1989
- Clinical Pharmacokinetics of VancomycinClinical Pharmacokinetics, 1986
- A prospective study of adverse reactions associated with vancomycin therapyJournal of Antimicrobial Chemotherapy, 1985
- Toxicology of Vancomycin in Laboratory AnimalsClinical Infectious Diseases, 1981